Basic information Safety Supplier Related

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-

Basic information Safety Supplier Related

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl- Basic information

Product Name:
1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-
Synonyms:
  • 1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-
  • P-CAB agent 2
  • Ornidazole Impurity 46
  • Keverprazan
  • 1-(5-(2-Fluorophenyl)-1-((3-(3-methoxypropoxy)phenyl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine
CAS:
1978371-23-1
MF:
C22H25FN2O4S
MW:
432.51
Mol File:
1978371-23-1.mol
More
Less

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl- Chemical Properties

Boiling point:
587.5±60.0 °C(Predicted)
Density 
1.23±0.1 g/cm3(Predicted)
form 
Oil
pka
9.18±0.10(Predicted)
color 
Light brown to brown
More
Less

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl- Usage And Synthesis

Uses

P-CAB agent 2 is a potent and orally active potassium-competitive acid blocker and a gastric acid secretion inhibitor. P-CAB agent 2 inhibits H+/K+-ATPase activity with an IC50 value of <100 nM. P-CAB agent 2 inhibits the hERG potassium channel with an IC50 value of 18.69 M. P-CAB agent 2 shows no acute toxicity and inhibits histamine (HY-B1204)-induced gastric acid secretion[1].

in vivo

P-CAB agent 2 (example 1) inhibits histamine (HY-B1204)-induced gastric acid secretion in SD rats[1].
P-CAB agent 2 (600, 2000 mg/kg; p.o.; once) shows no acute toxicity and 600mg/kg shows no significant effect on animal body weight in SD rats[1].

Animal Model:180-220 g, SPF grade, male SD rats[1]
Dosage:2 mg/kg
Administration:P.o.; once
Result:Inhibited histamine-induced gastric acid secretion with the acid suppression rate of 55.4%.

References

[1] YinLin Qin, et al. Pyrrole sulfonyl derivative, and preparation method and medical use thereof. WO2016119505A1.

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-Supplier

CONIER CHEM AND PHARMA LIMITED
Tel
+8618523575427
Email
sales@conier.com
Nanjing webright Pharmaceutical Technology Co., Ltd
Tel
18066048793; 18014498793
Email
1504914633@qq.com
NanJing Vtrying Pharmatech Co.,Ltd
Tel
17314186806
Email
Vtrying_sale@163.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Shandong Huijing bio-pharmaceutical Technology Co. , Ltd.
Tel
15192151674
Email
1726957134@qq.com
More
Less

1H-Pyrrole-3-methanamine, 5-(2-fluorophenyl)-1-[[3-(3-methoxypropoxy)phenyl]sulfonyl]-N-methyl-(1978371-23-1)Related Product Information